Literature DB >> 24897986

Polymyalgia rheumatica: clinical update.

Faisal Ameer1, Julian McNeil.   

Abstract

BACKGROUND: Polymyalgia rheumatica is a relatively common inflammatory rheumatic disease. There are no validated international guidelines available for the diagnosis and treatment of PMR; however, diagnostic and classification criteria are currently being developed.
OBJECTIVE: The aim of this article is to summarise the main management options suggested by American College of Rheumatology and discusses the role of the general practitioner in the diagnosis and early management of PMR. DISCUSSION: Diagnosis is made on the basis of a combination of clinical and laboratory findings. Patients typically present with shoulder and hip girdle pain with pronounced stiffness. Inflammatory markers are usually elevated and an ultrasound and MRI of the shoulder and hip can be done to localise inflamed tissues. Response to steroids should not be used as a defining feature of PMR but treatment with low dose prednisone should be considered. PMR has an excellent prognosis if diagnosis is prompt and therapy adequate.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24897986

Source DB:  PubMed          Journal:  Aust Fam Physician        ISSN: 0300-8495


  2 in total

1.  [Polymyalgia rheumatica in 18-fluorodeoxyglucose-positron-emission-tomography/computed tomography : Improvement in diagnostic accuracy and differentiation from rheumatoid arthritis].

Authors:  F Witte; H-J Lakomek; J Holzinger; W-D Reinbold
Journal:  Z Rheumatol       Date:  2021-12-01       Impact factor: 1.372

2.  A qualitative study of patient perspectives related to glucocorticoid therapy in polymyalgia rheumatica and giant cell arteritis.

Authors:  Elizabeth Hoon; Carlee Ruediger; Tiffany K Gill; Rachel J Black; Catherine L Hill
Journal:  Open Access Rheumatol       Date:  2019-08-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.